170 related articles for article (PubMed ID: 8049652)
1. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
2. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
3. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
[TBL] [Abstract][Full Text] [Related]
5. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Gaiger A; Henn T; Hörth E; Geissler K; Mitterbauer G; Maier-Dobersberger T; Greinix H; Mannhalter C; Haas OA; Lechner K; Lion T
Blood; 1995 Sep; 86(6):2371-8. PubMed ID: 7662984
[TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
7. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
Martinelli G; Zaccaria A; Farabegoli P; Buzzi M; Testoni N; Bragliani M; Panzica G; Tura S
Leuk Lymphoma; 1993; 11 Suppl 1():51-6. PubMed ID: 8251917
[TBL] [Abstract][Full Text] [Related]
8. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
Rooke HM; Vitas MR; Crosier PS; Crosier KE
Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
[TBL] [Abstract][Full Text] [Related]
9. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
11. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
Li Z; Luo J
Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
[TBL] [Abstract][Full Text] [Related]
12. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.
Okabe M; Kunieda Y; Nakane S; Kurosawa M; Itaya T; Vogler WR; Shoji M; Miyazaki T
Leuk Lymphoma; 1995 Feb; 16(5-6):493-503. PubMed ID: 7787756
[TBL] [Abstract][Full Text] [Related]
14. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP
Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180
[TBL] [Abstract][Full Text] [Related]
15. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
LeMaistre A; Lee MS; Talpaz M; Kantarjian HM; Freireich EJ; Deisseroth AB; Trujillo JM; Stass SA
Blood; 1989 Mar; 73(4):889-91. PubMed ID: 2645949
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan.
Tien HF; Chuang SM; Wang CH; Lee FY; Chien SH; Chen YC; Shen MC; Liu CH
Cancer Genet Cytogenet; 1989 May; 39(1):89-97. PubMed ID: 2731152
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelocytic leukemia with myeloblastoma has higher frequency of ras oncogene mutation.
Tanaka K; Takauchi K; Takechi M; Dohy H; Kamada N
Leuk Res; 1992 Sep; 16(9):947. PubMed ID: 1405725
[No Abstract] [Full Text] [Related]
18. Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia.
Spencer A; Vulliamy T; Kaeda J; Goldman JM; Melo JV
Leukemia; 1997 Feb; 11(2):195-201. PubMed ID: 9009080
[TBL] [Abstract][Full Text] [Related]
19. Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia.
Gow J; Hughes D; Farr C; Hamblin T; Oscier D; Brown R; Padua RA
Leuk Res; 1988; 12(10):805-10. PubMed ID: 3059070
[TBL] [Abstract][Full Text] [Related]
20. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]